A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K–Akt signalling

Top Cited Papers
Publisher Website
Google Scholar
Abstract
Mutations in the parkin gene are responsible for a common familial form of Parkinson's disease1,2. As parkin encodes an E3 ubiquitin ligase3, defects in proteasome-mediated protein degradation are believed to have a central role in the pathogenesis of Parkinson's disease4. Here, we report a novel role for parkin in a proteasome-independent ubiquitination pathway. We have identified a regulated interaction between parkin and Eps15, an adaptor protein that is involved in epidermal growth factor (EGF) receptor (EGFR) endocytosis and trafficking5. Treatment of cells with EGF stimulates parkin binding to both Eps15 and the EGFR and promotes parkin-mediated ubiquitination of Eps15. Binding of the parkin ubiquitin-like (Ubl) domain to the Eps15 ubiquitin-interacting motifs (UIMs) is required for parkin-mediated Eps15 ubiquitination. Furthermore, EGFR endocytosis and degradation are accelerated in parkin-deficient cells, and EGFR signalling via the phosphoinositide 3-kinase (PI(3)K)–Akt pathway is reduced in parkin knockout mouse brain. We propose that by ubiquitinating Eps15, parkin interferes with the ability of the Eps15 UIMs to bind ubiquitinated EGFR6,7,8, thereby delaying EGFR internalization and degradation, and promoting PI(3)K–Akt signalling. Considering the role of Akt in neuronal survival9, our results have broad new implications for understanding the pathogenesis of Parkinson's disease.